CTRI/2020/04/024466
Not yet recruiting
Phase 2
A Randomized Controlled Clinical Study Of Efficacy Of Ketakyadi Taila In Asthigata Vata w.s.r. ToOsteoporosis
Dr Ardra Bhagwatrao Thorat0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: E58- Dietary calcium deficiency
- Sponsor
- Dr Ardra Bhagwatrao Thorat
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.BMD less than or equal to \-2\.5
- •2\.If diabetic patients BSL random less than 200mg /dl
- •3\.BMR less than 25
Exclusion Criteria
- •1\.Patients having any congenital bone disease
- •2\.Patients having tuberculosis, endocrinal disease,any malignancies, bone tumor,other metabolic bone disease
- •3\.Patients taking or require Hormone therapy
- •4\.Patients taking steroidal therapy
- •5\.Patients immediately require any surgical interventions for their
- •bone and joint disease
- •6\.Any complication arises during the treatment or if any patient discontinue the treatment will be rejected
- •7\.ANC and PNC female
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
To Study the Efficacy of Chaturjat Pradhaman Nasya and Vyoshadi Vati Orally in Dushtapratishyaya With Special Reference to Chronic Rhinosinusitis.Health Condition 1: - Health Condition 2: J018- Other acute sinusitisCTRI/2019/08/020532Government ayurved college
Not yet recruiting
Phase 2
Effect Of Mango Tender Leaves In Newborn JaundiceCTRI/2020/03/024403Sri Sri College Of Ayurvedic Science And Research
Completed
Not Applicable
Effect of Lohabhasma on Iron Deficiency Anemia In Pregnany.Health Condition 1: O268- Other specified pregnancy relatedconditionsCTRI/2018/12/016537Dr S D Katakdound100
Not yet recruiting
Phase 2
A clinical trial to study the effect of Virechan karma in Prediabetes in Overweight people.CTRI/2020/11/029248Vidya Boinwad
Recruiting
Phase 2
Efficacy of apamarga kshar internally in the management of hyperlipidemiaHealth Condition 1: E669- Obesity, unspecifiedCTRI/2023/05/052998Shraddha Siddheshwar Mule